The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 10, 2012
Filed:
May. 16, 2006
Jeannie Chow Wong, Jersey City, NJ (US);
Benjamin Max Cohen, Cranford, NJ (US);
Aaron S. Cote, West Windsor, NJ (US);
Erik A. Dienemann, Metuchen, NJ (US);
Kimberly Gallagher, Green Lane, PA (US);
Craig Ikeda, Harleysville, PA (US);
Justin Moser, Collegeville, PA (US);
Pavol Rajniak, Lansdale, PA (US);
Robert A. Reed, Line Lexington, PA (US);
Brian Sell, Royersford, PA (US);
Cindy Starbuck, Doylestown, PA (US);
Hsien-hsin Tung, Grayslake, IL (US);
Qingxi Wang, Ambler, PA (US);
Vincent R. Capodanno, Hillsborough, NJ (US);
Jeannie Chow Wong, Jersey City, NJ (US);
Benjamin Max Cohen, Cranford, NJ (US);
Aaron S. Cote, West Windsor, NJ (US);
Erik A. Dienemann, Metuchen, NJ (US);
Kimberly Gallagher, Green Lane, PA (US);
Craig Ikeda, Harleysville, PA (US);
Justin Moser, Collegeville, PA (US);
Pavol Rajniak, Lansdale, PA (US);
Robert A. Reed, Line Lexington, PA (US);
Brian Sell, Royersford, PA (US);
Cindy Starbuck, Doylestown, PA (US);
Hsien-Hsin Tung, Grayslake, IL (US);
Qingxi Wang, Ambler, PA (US);
Vincent R. Capodanno, Hillsborough, NJ (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
The present invention provides a pharmaceutical composition or crystalline composition with a specific dissolution profile, which comprises suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The present invention provides a process of producing said crystalline composition or pharmaceutical composition. The present invention also provides compositions with a specific particle size distribution.